TODAY

2024. 06. 20.

D-77

Scientific Program

  • 15:00-16:30

    Best Article in JOMES

    15:00-15:30

    15:30-16:00

    16:00-16:30

  • 16:30-16:40

    Break

  • 18:10-18:40

    Satellite Symposium 1

    will be updated.
    18:10-18:40

  • 18:40-19:10

    Satellite Symposium 2

    will be updated.
    18:40-19:10

  • 15:00-16:30

    Joint Symposium KSSO-JKT (Basic)

    will be updated.
    15:00-15:30

    15:30-16:00

    16:00-16:30

  • 16:30-16:40

    Break

  • 16:40-18:10

    Joint Symposium KSSO-JKT (Clinical)

    will be updated.
    16:40-17:10

    17:10-17:40

    17:40-18:10

  • 18:10-18:40

    Satellite Symposium 3

    will be updated.
    18:10-18:40

  • 15:00-16:30

    Committee Session

    will be updated.
    15:00-15:30

    15:30-16:00

    16:00-16:30

  • 19:10-21:00

    Textbook Publication Inauguration Ceremony & Welcome Cocktail Party

  • 07:30-08:20

    Breakfast Symposium 1

    will be updated.
    07:30-08:20

  • 08:20-08:30

    Break

  • 08:30-09:10

    Keynote Lecture 1

    Organizer : Jang Won Son (The Catholic University of Korea, Republic of Korea)

    • Professor Thiruma V. Arumugam, a distinguished researcher in the fields of physiology and pharmacology at La Trobe University, Australia, is pushing the boundaries of neuroscience and metabolism. In his upcoming lecture, he will discuss how his work on intermittent metabolic switching has enhanced our comprehension of its effect on brain health, paving the way for potential therapeutic interventions.
    • His recent publication in Theranostics, titled "Time-restricted feeding modulates the DNA methylation landscape, attenuates hallmark neuropathology and cognitive impairment in a mouse model of vascular dementia," has presented novel insights into the therapeutic potential of intermittent metabolic switching, offering promising strategies for managing and potentially reversing cognitive impairment in dementia.
    • Further expanding our understanding, Professor Arumugam's article in Cell Metabolism, "Hallmarks of Brain Aging: Adaptive and Pathological Modification by Metabolic States," continues to revolutionize our perspective on the role of metabolism in brain aging.
    08:30-09:00 A Novel Platform to Identify Hypothalamic Targets Regulating Energy Balance and Metabolism

    Joel K. Elmquist

    (UT Southwestern Medical Center, USA)
    09:00-09:10 Q&A
  • 09:10-09:20

    Break

  • 09:20-10:50

    Symposium 1 : Precision Medicine for Obesity and Diabetes

    Organizer: Seung-Hwan Lee (The Catholic University of Korea, Republic of Korea), Jae Hyun Bae (Korea University, Republic of Korea)

    • Obesity is strongly associated with increased incidence and progression of cancers, significantly contributing to cancer-related mortality. This session will delve into the latest perspectives on the relationship between obesity and cancer. Professor Yun Kyung Cho will present epidemiological studies that elucidate the impact of obesity on cancer risk. Professor Haejin Yoon will explore the regulation of mitochondrial metabolism and its role in metabolic diseases. Professor Annie Anderson will discuss evidence-based strategies to effectively address excess body fatness in cancer survivors.
    • • References
      1. Cho YK, Lee J, Kim HS, et al. Metabolic health is a determining factor for incident colorectal cancer in the obese population: A nationwide population-based cohort study. Cancer Med. 2021;10(1):220-229.
      2. Yoon H, Spinelli JB, Zaganjor E, et al. PHD3 loss promotes exercise capacity and fat oxidation in skeletal muscle. Cell Metab. 2020;32(2):215-228.
      3. Anderson AS, Martin RM, Renehan AG, et al. Cancer survivorship, excess body fatness and weight-loss intervention-where are we in 2020? Br J Cancer. 2021;124(6):1057-1065
    09:20-09:45 Obesity Phenotypes and Precision Medicine

    Jean-Pierre Després

    (VITAM – Research Centre on Sustainable Health, Canada)
    09:45-10:10

    Yoon Jung Park

    (Ewha Womans University, Korea)
    10:10-10:35

    Jun Yeop Lee

    (The Catholic University of Korea, Korea)
    10:35-10:50 Panel Discussion
  • 10:50-11:00

    Break

  • 11:00-11:10

    Opening Address

  • 11:10-11:50

    Keynote Lecture 2

    Organizer: Soo Lim (Seoul National University, Republic of Korea)

    • Matthias Blüher is Head of the Obesity Outpatient Clinic for Adults at the University of Leipzig Department of Medicine in Leipzig, Germany. He is Professor of Molecular Endocrinology, with board certifications in Internal Medicine, Endocrinology and Diabetology. From 2006 to 2012, Professor Blüher served as Head of the Clinical Research Group ‘Atherobesity,’ and since 2013, he has been Speaker of the Collaborative Research Center on obesity mechanisms.
    • Professor Blüher has won several awards, including the Obesity Research Award of the German Society for the Study of Obesity, the Ferdinand-Bertram-Prize of the German Diabetes Association, and the Rising Star Lecture at the 44th European Association for the Study of Diabetes (EASD) meeting. More recently, he received the Hans Christian Hagedorn Award from the German Diabetes Association in 2011 and the Minkowski Award from the EASD in 2015.
    • • References
      1. Blüher M, Aras M, Aronne LJ, Batterham RL, Giorgino F, Ji L, Pietiläinen KH, Schnell O, Tonchevska E, Wilding JPH. New insights into the treatment of obesity. Diabetes Obes Metab. 2023 Apr 13. doi: 10.1111/dom.15077.
      2. Blüher M. Metabolically Healthy Obesity. Endocr Rev. 2020 May 1;41(3):bnaa004.
    11:10-11:40 GLP-1 Based Therapy of Obesity

    Michael A. Nauck

    (Ruhr-University Bochum, Germany)
    11:40-11:50 Q&A
  • 11:50-12:00

    Break

  • 12:00-13:00

    Luncheon Symposium 1

    will be updated.
    12:00-13:00

  • 13:00-14:00

    Break

  • 14:00-15:30

    Symposium 5 : Current Perspectives on Health Inequity in Obesity

    Organizer: Kyung Hee Park (Hallym University, Republic of Korea), Jin-Wook Kim (Hippocrata Clinic), Yoon Jeong Cho (Daegu Catholic University, Republic of Korea)

    • The development of new drugs for treating obesity is ongoing, and more potent medications are being introduced. Among them, semaglutide and tirzepatide will soon be available in Korea, and their efficacy has been proven based on various clinical trials. In Symposium 5, we will discuss the efficacy of semaglutide and tirzepatide, as well as expectations and side effects associated with their use. In line with this, we will explore the safety and status of drug abuse when using anti-obesity drugs, which should be considered as important as their efficacy. This symposium will provide an opportunity for us to collectively contemplate the direction for optimal treatment in this field.
    • • References
      1. J Obes Metab Syndr. 2023 Jun 30; 32(2): 121–129. Diagnosis of Obesity: 2022 Update of Clinical Practice Guidelines for Obesity by the Korean Society for the Study of Obesity
      2. Lancet Diabetes Endocrinol 2022; 10: 193–206. Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial
      3. Diabetes Obes Metab. 2023 Apr;25(4):1056-1067. Safety and efficacy analyses across age and body mass index subgroups in East Asian participants with type 2 diabetes in the phase 3 tirzepatide studies (SURPASS programme)
      4. Diabetes Obes Metab.2021;23:1232–1241.Cardiovascular safety of evogliptin in patients with type 2 diabetes: A nationwide cohort study.
    14:00-14:25 Obesity Related Health Disparities - A Specific Case of Low- and Middle-Income Countries

    Monika Chaudhary

    (IIHMR University,India)
    14:25-14:50 The Food Insecurity - Obesity Paradox and Strategies to Address Food Insecurity

    Seul Ki Choi

    (University of Seoul, Korea)
    14:50-15:15 Managing Weight in Urban Neighborhoods: Qualitative Case Studies

    Seunghyun Yoo

    (Seoul National University, Korea)
    15:15-15:30 Panel Discussion
  • 15:30-15:40

    Break

  • 15:40-16:20

    Keynote Lecture 3

    Organizer: Il-Young Kim (Gachon University, Republic of Korea)

    • Prof. Wolfe is widely respected as the world’s foremost authority on stable isotope tracer methodology and on amino acid/protein nutrition. His research focuses on the regulation of muscle metabolism, particularly as affected by aging, obesity, insulin resistance, and stressors such as sepsis and cancer in humans. Prof. Wolfe has developed numerous metabolic tracing models using stable isotope tracers to quantify a variety of metabolic processes in humans, which has formed the foundation of our understanding of many aspects of normal and abnormal metabolism of glucose, fatty acid, and amino acid/protein in humans. In his plenary lecture, the particular emphasis will be placed on the response of fatty acid kinetics to different conditions (exercise, glucose intake, obesity) in the context of the triglyceride-fatty acid cycle, with his more than 50 years of experience in the human metabolic research.
    • • References
      1. Kim IY et al., Tracing metabolic flux in vivo: basic model structures of tracer methodology. 2022 Sep;54(9):1311-1322. doi: 10.1038/s12276-022-00814-z.
      2. Miyoshi H et al., Hormonal control of substrate cycling in humans, J Clin Invest. 1988. 1988 May;81(5):1545-55. doi: 10.1172/JCI113487.
      3. Sidossis LS, Wolfe RR. Glucose and insulin-induced inhibition of fatty acid oxidation: the glucose-fatty acid cycle reversed. Am J Physiol. 1996 Apr;270(4 Pt 1):E733-8. doi: 10.1152/ajpendo.1996.270.4.E733. PMID: 8928782.
    15:40-16:10 Management of Youth Type 2 Diabetes: New Pharmacotherapeutic Modalities

    Silva Arslanian

    (University of Pittsburgh, USA)
    16:10-16:20 Q&A
  • 16:20-16:30

    Break

  • 16:30-18:00

    Symposium 9 : Obesity and Cardiovascular Health

    Organizer: Yun-Hee Lee (Seoul National University, Republic of Korea)

    • The topic of this session is “Obesity in special conditions”. Beyond recognizing obesity as the same disease condition, we would like to have time to look at cases with various accompanying diseases. The first speaker, Dicky L. Tahapary, will discuss the diagnosis and treatment of obese patients with diabetes. The second speaker, Wen-Yuan Lin, will introduce studies related to obesity with sarcopenia. The last speaker, Professor Tae Nyun Kim, will discuss the new concept of osteoporosis-sarcopenic obesity.
    16:30-16:55

    16:55-17:20

    Kyung-Hee Kim

    (Incheon Sejong Hospital, Korea)
    17:20-17:45

    17:45-18:00 Panel Discussion
  • 07:30-08:20

    Breakfast Symposium 2

    will be updated.
    07:30-08:20

  • 08:20-08:30

    Break

  • 08:30-09:10

    Keynote Lecture 1

    Organizer : Jang Won Son (The Catholic University of Korea, Republic of Korea)

    • Professor Thiruma V. Arumugam, a distinguished researcher in the fields of physiology and pharmacology at La Trobe University, Australia, is pushing the boundaries of neuroscience and metabolism. In his upcoming lecture, he will discuss how his work on intermittent metabolic switching has enhanced our comprehension of its effect on brain health, paving the way for potential therapeutic interventions.
    • His recent publication in Theranostics, titled "Time-restricted feeding modulates the DNA methylation landscape, attenuates hallmark neuropathology and cognitive impairment in a mouse model of vascular dementia," has presented novel insights into the therapeutic potential of intermittent metabolic switching, offering promising strategies for managing and potentially reversing cognitive impairment in dementia.
    • Further expanding our understanding, Professor Arumugam's article in Cell Metabolism, "Hallmarks of Brain Aging: Adaptive and Pathological Modification by Metabolic States," continues to revolutionize our perspective on the role of metabolism in brain aging.
    08:30-09:00 A Novel Platform to Identify Hypothalamic Targets Regulating Energy Balance and Metabolism

    Joel K. Elmquist

    (UT Southwestern Medical Center, USA)
    09:00-09:10 Q&A
  • 09:10-09:20

    Break

  • 09:20-10:50

    Symposium 2 : Gut, Brain, and Obesity

    Organizer : Jang Won Son (The Catholic University of Korea, Republic of Korea), Kyung Ae Lee (Jeonbuk National University)

    • In this session, Professor Thiruma V. Arumugam will elucidate on the transformative effects of dietary restriction on vascular dementia, providing invaluable insights into how our eating habits can directly impact our cognitive health. Following him, Professor Dong Gyu Jo will elaborate on adiponectin's role in Alzheimer's Disease, offering clues for potential therapeutic strategies. Lastly, Professor Theresia Handayani Mina will explore the link between body fat, metabolic risks, and cognitive function.
    • • References
      1. Hallmarks of Brain Aging: Adaptive and Pathological Modification by Metabolic States. Cell Metab. 2018 Jun 5;27(6):1176-1199.
      2. Physiology and pharmacology of amyloid precursor protein. Pharmacol Ther. 2022 Jul;235:108122.
      3. Adiposity impacts cognitive function in Asian populations: an epidemiological and Mendelian Randomization study. Lancet Reg Health West Pac. 2023 Feb 14;33:100710.
    09:20-09:45 Cross-talk Between the Gut (Microbiota) and Peripheral Organs in Obesity

    Chih-Yen Chen

    (National Yang Ming Chiao Tung University, Taiwan)
    09:45-10:10 Decoding VMH Regulation of Food Intake in Adults

    Teppei Fujikawa

    (UT Southwestern Medical Center, USA)
    10:10-10:35 A Microbiota-Derived Short Chain Fatty Acid Targets the Hypothalamus and Regulates Energy Balance

    Ki Woo Kim

    (Yonsei University, Korea)
    10:35-10:50 Panel Discussion
  • 10:50-11:00

    Break

  • 11:00-11:10

    Opening Address

  • 11:10-11:50

    Keynote Lecture 2

    Organizer: Soo Lim (Seoul National University, Republic of Korea)

    • Matthias Blüher is Head of the Obesity Outpatient Clinic for Adults at the University of Leipzig Department of Medicine in Leipzig, Germany. He is Professor of Molecular Endocrinology, with board certifications in Internal Medicine, Endocrinology and Diabetology. From 2006 to 2012, Professor Blüher served as Head of the Clinical Research Group ‘Atherobesity,’ and since 2013, he has been Speaker of the Collaborative Research Center on obesity mechanisms.
    • Professor Blüher has won several awards, including the Obesity Research Award of the German Society for the Study of Obesity, the Ferdinand-Bertram-Prize of the German Diabetes Association, and the Rising Star Lecture at the 44th European Association for the Study of Diabetes (EASD) meeting. More recently, he received the Hans Christian Hagedorn Award from the German Diabetes Association in 2011 and the Minkowski Award from the EASD in 2015.
    • • References
      1. Blüher M, Aras M, Aronne LJ, Batterham RL, Giorgino F, Ji L, Pietiläinen KH, Schnell O, Tonchevska E, Wilding JPH. New insights into the treatment of obesity. Diabetes Obes Metab. 2023 Apr 13. doi: 10.1111/dom.15077.
      2. Blüher M. Metabolically Healthy Obesity. Endocr Rev. 2020 May 1;41(3):bnaa004.
    11:10-11:40 GLP-1 Based Therapy of Obesity

    Michael A. Nauck

    (Ruhr-University Bochum, Germany)
    11:40-11:50 Q&A
  • 11:50-12:00

    Break

  • 12:00-13:00

    Luncheon Symposium 2

    will be updated.
    12:00-13:00

  • 13:00-14:00

    Break

  • 14:00-15:30

    Symposium 6 : Holistic Approach to Obesity Management: Exploring Exercise, Metabolism, and Muscle Health

    Organizer : Sewon Lee (Incheon National University, Korea), Minchul Lee (CHA University, Korea)

    • Symposium 6 aims to comprehensively explore the roles of exercise-induced mitochondrial controls in skeletal muscle, novel strategies in managing NAFLD focusing on muscle metabolism and exercise, and the impact of exercise intervention on sarcopenia and menopause in women. By taking a holistic approach, this symposium delves into various aspects of obesity management, examining the interplay between exercise, metabolism, and muscle health.
    14:00-14:25 Exercise-Induced Mitochondrial Controls in Skeletal Muscle

    Yuho Kim

    (University of Massachusetts-Lowell, USA)
    14:25-14:50 Lifestyle Strategies in the Management of MAFLD: The Role of Muscle Metabolism and Exercise

    Sechang Oh

    (R Professional University of Rehabilitation, Japan)
    14:50-15:15 Sarcopenia, Menopause, and Exercise Intervention in Women

    Young-Min Park

    (Incheon National University, Korea)
    15:15-15:30 Panel Discussion
  • 15:30-15:40

    Break

  • 15:40-16:20

    Keynote Lecture 3

    Organizer: Il-Young Kim (Gachon University, Republic of Korea)

    • Prof. Wolfe is widely respected as the world’s foremost authority on stable isotope tracer methodology and on amino acid/protein nutrition. His research focuses on the regulation of muscle metabolism, particularly as affected by aging, obesity, insulin resistance, and stressors such as sepsis and cancer in humans. Prof. Wolfe has developed numerous metabolic tracing models using stable isotope tracers to quantify a variety of metabolic processes in humans, which has formed the foundation of our understanding of many aspects of normal and abnormal metabolism of glucose, fatty acid, and amino acid/protein in humans. In his plenary lecture, the particular emphasis will be placed on the response of fatty acid kinetics to different conditions (exercise, glucose intake, obesity) in the context of the triglyceride-fatty acid cycle, with his more than 50 years of experience in the human metabolic research.
    • • References
      1. Kim IY et al., Tracing metabolic flux in vivo: basic model structures of tracer methodology. 2022 Sep;54(9):1311-1322. doi: 10.1038/s12276-022-00814-z.
      2. Miyoshi H et al., Hormonal control of substrate cycling in humans, J Clin Invest. 1988. 1988 May;81(5):1545-55. doi: 10.1172/JCI113487.
      3. Sidossis LS, Wolfe RR. Glucose and insulin-induced inhibition of fatty acid oxidation: the glucose-fatty acid cycle reversed. Am J Physiol. 1996 Apr;270(4 Pt 1):E733-8. doi: 10.1152/ajpendo.1996.270.4.E733. PMID: 8928782.
    15:40-16:10 Management of Youth Type 2 Diabetes: New Pharmacotherapeutic Modalities

    Silva Arslanian

    (University of Pittsburgh, USA)
    16:10-16:20 Q&A
  • 16:20-16:30

    Break

  • 16:30-18:00

    Symposium 10

    Organizer: Hyung Jin Choi (Seoul National University, Republic of Korea)

    • In this session, we will delve into the intricate interplay between neuropsychology and obesity. Dr. Yun Ha Jeong from the Korea Brain Research Institute will discuss the impact of obesity and HDL concentration on the pathology of Alzheimer's disease (AD). Through an analysis of AD pathological changes in 5XFAD mice after obesity induction through a high-fat diet, Dr. Jeong presents a noteworthy phenomenon where the increase in HDL and APOA-I serum levels mitigates AD features, offering a potential avenue for novel therapeutic strategies.
    • Subsequently, Professor Kwang Wei Tham from Singapore Woodlands Health will elucidate how weight-related biases affect the physical, mental health, and obesity management of individuals. Lastly, Professor Youn Huh from Eulji University will explore the link between type 2 diabetes and dementia, emphasizing the growing relevance of preventing and managing these conditions, and discussing how type 2 diabetes escalates dementia risks, urging the derivation of preventive strategies based on research findings in light of the increasing prevalence of both diseases.
    16:30-16:55

    Emma Fontvieille

    (IARC - International Agency for Research on Cancer / World Health Organization, France)
    16:55-17:20

    17:20-17:45

    Wonsock Kim

    (Eulji University, Korea)
    17:45-18:00 Panel Discussion
  • 07:30-08:20

    Breakfast Symposium 3

    will be updated.
    07:30-08:20

  • 08:20-08:30

    Break

  • 08:30-09:10

    Keynote Lecture 1

    Organizer : Jang Won Son (The Catholic University of Korea, Republic of Korea)

    • Professor Thiruma V. Arumugam, a distinguished researcher in the fields of physiology and pharmacology at La Trobe University, Australia, is pushing the boundaries of neuroscience and metabolism. In his upcoming lecture, he will discuss how his work on intermittent metabolic switching has enhanced our comprehension of its effect on brain health, paving the way for potential therapeutic interventions.
    • His recent publication in Theranostics, titled "Time-restricted feeding modulates the DNA methylation landscape, attenuates hallmark neuropathology and cognitive impairment in a mouse model of vascular dementia," has presented novel insights into the therapeutic potential of intermittent metabolic switching, offering promising strategies for managing and potentially reversing cognitive impairment in dementia.
    • Further expanding our understanding, Professor Arumugam's article in Cell Metabolism, "Hallmarks of Brain Aging: Adaptive and Pathological Modification by Metabolic States," continues to revolutionize our perspective on the role of metabolism in brain aging.
    08:30-09:00 A Novel Platform to Identify Hypothalamic Targets Regulating Energy Balance and Metabolism

    Joel K. Elmquist

    (UT Southwestern Medical Center, USA)
    09:00-09:10 Q&A
  • 09:10-09:20

    Break

  • 09:20-10:50

    Symposium 3 : Possibilities and Prospects of Digital Therapeutics for Metabolic Diseases

    Organizer: Sang Youk Rhee (Kyung Hee University, Republic of Korea)

    • This session aims to explore the latest status of intervention methodology based on Information and Communication Technologies (ICTs) for the management of diverse chronic diseases, such as obesity and metabolic syndrome. First, Professor Ki-Hyun Jeon from Seoul National University will open the session by introducing the latest research advancements in the related field, including his own studies. Doctor Laura Falvey from Reset Health will then present highly reliable evidence for the remarkable effects of digital treatment methods based on the results of randomized controlled trials (RCTs) from the Roczen Programme, which were recently released at the European Congress on Obesity. Lastly, Professor Sang Youl Rhee from Kyung Hee University will discuss the effectiveness of the ICT-based intervention and the necessary approaches for their wide use in various chronic disease patients in the future, drawing on a wealth of literature introduced thus far, including systematic literature reviews.
    09:20-09:45 Possibility of Digital Therapeutics for Treatment and Management of Metabolic Diseases

    Sang Youl Rhee

    (Kyung Hee University, Korea)
    09:45-10:10 Psychological Basis for the Effectiveness of Digital Therapeutics for Metabolic Diseases

    Hyung Jin Choi

    (Seoul National University, Korea)
    10:10-10:35 Suggestions for Integrating Digital Therapeutics into Conventional Medical Settings

    Min Kyu Han

    (Kakao Healthcare, Korea)
    10:35-10:50 Panel Discussion
  • 10:50-11:00

    Break

  • 11:00-11:10

    Opening Address

  • 11:10-11:50

    Keynote Lecture 2

    Organizer: Soo Lim (Seoul National University, Republic of Korea)

    • Matthias Blüher is Head of the Obesity Outpatient Clinic for Adults at the University of Leipzig Department of Medicine in Leipzig, Germany. He is Professor of Molecular Endocrinology, with board certifications in Internal Medicine, Endocrinology and Diabetology. From 2006 to 2012, Professor Blüher served as Head of the Clinical Research Group ‘Atherobesity,’ and since 2013, he has been Speaker of the Collaborative Research Center on obesity mechanisms.
    • Professor Blüher has won several awards, including the Obesity Research Award of the German Society for the Study of Obesity, the Ferdinand-Bertram-Prize of the German Diabetes Association, and the Rising Star Lecture at the 44th European Association for the Study of Diabetes (EASD) meeting. More recently, he received the Hans Christian Hagedorn Award from the German Diabetes Association in 2011 and the Minkowski Award from the EASD in 2015.
    • • References
      1. Blüher M, Aras M, Aronne LJ, Batterham RL, Giorgino F, Ji L, Pietiläinen KH, Schnell O, Tonchevska E, Wilding JPH. New insights into the treatment of obesity. Diabetes Obes Metab. 2023 Apr 13. doi: 10.1111/dom.15077.
      2. Blüher M. Metabolically Healthy Obesity. Endocr Rev. 2020 May 1;41(3):bnaa004.
    11:10-11:40 GLP-1 Based Therapy of Obesity

    Michael A. Nauck

    (Ruhr-University Bochum, Germany)
    11:40-11:50 Q&A
  • 11:50-12:00

    Break

  • 12:00-13:00

    Luncheon Symposium 3

    will be updated.
    12:00-13:00

  • 13:00-14:00

    Break

  • 14:00-15:30

    Symposium 7

    Organizer : Yun-Hee Lee (Seoul National University, Republic of Korea)

    • This conference session will explore the intriguing topic of "Metabolic Signaling in Obesity-related Diseases." Our esteemed speakers will present cutting-edge research and share their valuable insights. Our first speaker, Dr. Zach Gerhart-Hines, will showcase his recent accomplishments in the exploration of novel GPCR pathways for the treatment of obesity and type 2 diabetes.
    • Next, we have Dr. EH Koh, who will enlighten the audience about the pivotal role of the NLRP3 inflammasome in adipose tissue. Lastly, our final speaker Dr. JK Seong will delve into the metabolic roles of the microbiota in obesity mouse models., offering potential avenues for future research and treatment options.
    • • References
      1. Gerhart-Hines Z et al. Lipolysis drives expression of the constitutively active receptor GPR3 to induce adipose thermogenesis. Cell. 2021 Jun 24;184(13):3502-3518.e33.
      2. Koh EH, Lee KU et al. Mitophagy deficiency increases NLRP3 to induce brown fat dysfunction in mice. Autophagy. 2021 May;17(5):1205-1221.
      3. Seong JK. et al. Bifidobacterial carbohydrate/nucleoside metabolism enhances oxidative phosphorylation in white adipose tissue to protect against diet-induced obesity. Microbiome. 2022 Nov 4;10(1):188.
    14:00-14:25 Role of Lipid Droplets in Health and Cardiometabolic Disease

    Mottillo Emilio

    (Wayne State University, USA)
    14:25-14:50 Stromal Transdifferentiation Drives Lipomatosis and Induces Extensive Vascular Remodeling in the Aging Human Lymph Node

    Maria Ulvmar

    (Uppsala University, Sweden)
    14:50-15:15 The Functional Relevance of a Microbiome-Derived SCFA in Reprogramming Hepatic Lipid Metabolism

    Dong Wook Choi

    (Korea University, Korea)
    15:15-15:30 Panel Discussion

    Ja Hyun Koo

    (Seoul National University, Korea),

    Ki Yong Hong

    (Seoul National University, Korea)
  • 15:30-15:40

    Break

  • 15:40-16:20

    Keynote Lecture 3

    Organizer: Il-Young Kim (Gachon University, Republic of Korea)

    • Prof. Wolfe is widely respected as the world’s foremost authority on stable isotope tracer methodology and on amino acid/protein nutrition. His research focuses on the regulation of muscle metabolism, particularly as affected by aging, obesity, insulin resistance, and stressors such as sepsis and cancer in humans. Prof. Wolfe has developed numerous metabolic tracing models using stable isotope tracers to quantify a variety of metabolic processes in humans, which has formed the foundation of our understanding of many aspects of normal and abnormal metabolism of glucose, fatty acid, and amino acid/protein in humans. In his plenary lecture, the particular emphasis will be placed on the response of fatty acid kinetics to different conditions (exercise, glucose intake, obesity) in the context of the triglyceride-fatty acid cycle, with his more than 50 years of experience in the human metabolic research.
    • • References
      1. Kim IY et al., Tracing metabolic flux in vivo: basic model structures of tracer methodology. 2022 Sep;54(9):1311-1322. doi: 10.1038/s12276-022-00814-z.
      2. Miyoshi H et al., Hormonal control of substrate cycling in humans, J Clin Invest. 1988. 1988 May;81(5):1545-55. doi: 10.1172/JCI113487.
      3. Sidossis LS, Wolfe RR. Glucose and insulin-induced inhibition of fatty acid oxidation: the glucose-fatty acid cycle reversed. Am J Physiol. 1996 Apr;270(4 Pt 1):E733-8. doi: 10.1152/ajpendo.1996.270.4.E733. PMID: 8928782.
    15:40-16:10 Management of Youth Type 2 Diabetes: New Pharmacotherapeutic Modalities

    Silva Arslanian

    (University of Pittsburgh, USA)
    16:10-16:20 Q&A
  • 16:20-16:30

    Break

  • 16:30-18:00

    Symposium 11 : Perspectives in Digital Nutrition Care for Obesity

    will be updated.
    16:30-16:55 Applications of Digital Health and Nutrition Approaches for Obesity Prevention and Management in the Western Pacific Region

    Wen Peng

    (Qinghai University, China)
    16:55-17:20 Exploring the Landscape of Telenutrition in Obesity Management

    Melissa Ventura Marra

    (West Virginia University, USA)
    17:20-17:45 Telenutrition for Weight Management: Benefits, Limits, and Future Perspectives

    Shinok Park

    (Noom Korea, Korea)
    17:45-18:00 Panel Discussion
  • 09:20-10:50

    Symposium 4

    Organizer : Chang Hee Jung (University of Ulsan, Republic of Korea)

    • Numerous studies have been conducted on the association between the decline in muscle mass, known as sarcopenia, and cardio-metabolic diseases. Recently, there has been a growing interest in the quality of muscles, as research findings suggest that muscle quality is important in various aspects, in addition to muscle mass reduction.
    • Myosteatosis, an important factor determining muscle quality, has emerged as a risk factor for new cardio-metabolic diseases beyond sarcopenia. In this session, we aim to explore the prevalence of myosteatosis and its relationship with cardio-metabolic diseases. Furthermore, we aim to investigate its significance by comparing it with the accumulation of other ectopic fats.
    • • References
      1. Age-related changes in muscle quality and development of diagnostic cutoff points for myosteatosis in lumbar skeletal muscles
      measured by CT scan Clin Nutr. 2021 Jun;40(6):4022-4028.
      2. Association between sarcopenic obesity and poor muscle quality based on muscle quality map and abdominal computed tomography. Obesity (Silver Spring). 2023 Jun;31(6):1547-1557.
      Fat Distribution Patterns and Future Type 2 Diabetes Diabetes. 2022 Sep 1;71(9):1937-1945
    09:20-09:45

    Michael D. Jensen

    (Mayo College of Medicine, USA)
    09:45-10:10 The Role of GIP/or Glucagon Receptor Agonism in the Treatment of Obesity

    Michael A. Nauck

    (Ruhr-University Bochum, Germany)
    10:10-10:35

    Gary Sweeney

    (York University, Canada)
    10:35-10:50 Panel Discussion
  • 12:00-13:00

    Luncheon Symposium 4

    will be updated.
    12:00-13:00

  • 13:00-14:00

    Oral Presentation 1

    will be updated.
    13:00-13:10

    13:10-13:20

    13:20-13:30

    13:30-13:40

    13:40-13:50

  • 14:00-15:30

    Symposium 8

    will be updated.
    14:00-14:25

    14:25-14:50

    14:50-15:15

    15:15-15:30 Panel Discussion
  • 16:30-18:00

    Symposium 12 : Childhood Obesity is a Chronic Disease Demanding Specific Health Care

    Organizer: Jae Hyun Kim (Seoul National University, Republic of Korea), Yong Hee Hong (Soonchunhyang University, Republic of Korea)

    • As obesity in children and adolescents increases, we should take note of its development into obesity in adults, as well as its connection with type 2 diabetes in adolescents and young adults. In this session, we will explore the lifecycle perspective of obesity and type 2 diabetes, starting from childhood to adulthood, and gain an understanding of glucose patterns in children and adolescents with obesity and diabetes through continuous glucose measurement. Additionally, we will discuss recent advancements in new biomarkers associated with type 2 diabetes in obese children and adolescents.
    • • References
      1. Choi D, Kim S, Woo J, et al. Weight Change Alters the Small RNA Profile of Urinary Extracellular Vesicles in Obesity. Obes Facts. 2022;15(2):292-301.
      2. Choi IH, Yeom SW, Kim SY, You J, Kim JS, Kim M. Analysis of Cause-of-Death Mortality in Children and Young Adults with Diabetes: A Nationwide 10-Year Follow-Up Cohort Study. Children (Basel). 2023;10(2):358.
      3. Leister KR, Cilhoroz BT, Rosenberg J, Brown EC, Kim JY. Metabolic syndrome: Operational definitions and aerobic and resistance training benefits on physical and metabolic health in children and adolescents. Diabetes Metab Syndr. 2022;16(6):102530.
    16:30-16:55 Pediatric Obesity Prevention and Management in Korea: How to Do It in the Real World?

    Sochung Chung

    (Konkuk University, Korea)
    16:55-17:20 Nutritional Intervention Strategies for Childhood Obesity: The Role of the Dietitian

    Mary Easaw

    (Cardiac Vascular Sentral Kuala Lumpur, Malaysia)
    17:20-17:45 Adolescent Obesity: Complexities of Chronic Disease

    Silva Arslanian

    (University of Pittsburgh, USA)
    17:45-18:00 Panel Discussion

    Yeo-Jin Hong

    (Korea University Ansan Hospital, Korea)
  • 09:20-10:50

    Sponsored Session 1

    will be updated.
    09:20-09:50

    09:50-10:20

    10:20-10:50

  • 13:00-14:00

    Oral Presentation 2

    will be updated.
    13:00-13:10

    13:10-13:20

    13:20-13:30

    13:30-13:40

    13:40-13:50

  • 14:00-15:30

    Sponsored Session 2

    will be updated.
    14:00-14:30

    14:30-15:00

    15:00-15:30

  • 16:30-18:00

    Joint Symposium KSSO-EASO

    16:30-16:55

    16:55-17:20

    17:20-17:45

    17:45-18:00 Panel Discussion
  • 13:00-14:00

    Guided Poster Presentation 1

    will be updated.
    13:00-13:10

    13:10-13:20

    13:20-13:30

    13:30-13:40

    13:40-13:50

  • 18:30-20:30

    Congress Banquet *Invited Only

  • 07:30-08:20

    Breakfast Symposium 4

    will be updated.
    07:30-08:20

  • 08:20-08:30

    Break

  • 08:30-09:10

    Keynote Lecture 4

    Organizer: Jae Geun Kim (Incheon National University, Republic of Korea)

    • Professor Tamas Horvath is Chair of the Department of Comparative Medicine at Yale University School of Medicine in the United States and one of the leading researchers in the field of study on the hypothalamic control of energy homeostasis. In particular, his research on the regulation of synaptic plasticity by AgRP neurons in hypothalamic neuronal circuitries is one of his most noteworthy accomplishments. In this session, Professor Horvath will introduce the role of hypothalamic AgRP neurons that can be applied to obesity treatment.
    • • References
      1. Hunger-promoting AgRP neurons trigger an astrocyte-mediated feed-forward autoactivation loop in mice. J Clin Invest. 2021
      2. AgRP neurons control compulsive exercise and survival in an activity-based anorexia model. Nature Metabolism. 2020.
    08:30-09:00 Cardiometabolic Health: Importance of Lifestyle Vital Signs

    Jean-Pierre Després

    (VITAM - Research Centre on Sustainable Health, Canada)
    09:00-09:10 Q&A
  • 09:10-09:20

    Break

  • 09:20-10:50

    Symposium 13 : Obesity Related Comorbidity-Fatty Liver

    Organizer : Jun Hwa Hong (Eulji University, Republic of Korea)

    • In this session, we will explore the relationship between fatty liver associated with obesity and its diverse complications. Considering the recently increasing prevalence and growing interest in treatment of chronic kidney disease due to the introduction of SGLT2i, Professor Sang-Man Jin from Sungkyunkwan University School of Medicine will present data analyzing non-alcoholic fatty liver disease (NAFLD) and metabolic dysfunction-associated fatty liver disease (MAFLD) in relation to the cause of incident chronic kidney disease.
    • Professor Ming-Hua Zheng from China will analyze and present differences in implications for cardiovascular risk based on the cause of fatty liver. Particularly, Professor Bo-Kyung Koo from Seoul National University College of Medicine will explore data on factors related to the prognosis of cardiovascular and kidney disease, given the diverse impacts that complications in NAFLD patients have on cardiovascular and kidney conditions as well as liver condition.
    • We hope this session will assist you in managing the complications associated with MAFLD.
    • • References
      1. MAFLD and NAFLD in the prediction of incident chronic kidney disease. Sci Rep. 2023 Jan 31;13(1):1796.
      2. Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention. Cardiovasc Diabetol. 2022 Dec 3;21(1):270.
    09:20-09:45 Impact of Adipocyte Death on Steatotic Liver Disease (SLD)

    Seung-Jin Kim

    (Kangwon National University, Korea)
    09:45-10:10

    Hua Wang

    (First Affiliated Hospital of Anhui Medical University, China)
    10:10-10:35

    Jun Hwa Hong

    (Eulji University, Korea)
    10:35-10:50 Panel Discussion

    Bo Kyung Koo

    (Seoul National University, Korea),

    Youn Huh

    (Eulji University, Korea)
  • 10:50-11:00

    Break

  • 11:00-11:40

    Presidential Lecture

    Organizer: Soo Lim (Seoul National University, Republic of Korea), Jun Hwa Hong (Eulji University, Republic of Korea)

    • The interplay between adipose tissue's function as an energy reservoir and an endocrine organ is crucial for maintaining metabolic health. A key player in this dynamic balance is leptin, a hormone whose regulation is tightly linked to fat mass. Here we will discuss the multifaceted role of LATS1/2-YAP/TAZ signaling in regulating adipocyte plasticity and leptin production to maintain metabolic homeostasis.
    • • References
      1. Sethi, J.K. and A.J. Vidal-Puig, Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res, 2007. 48(6): p. 1253-62.
      2. Halder, G. and R.L. Johnson, Hippo signaling: growth control and beyond. Development, 2011. 138(1): p. 9-22.
    11:00-11:30

    Cheol-Young Park

    (Sungkyunkwan University, Korea)
    11:30-11:40 Q&A

  • 11:40-11:50

    Break

  • 11:50-12:50

    Luncheon Symposium 5

    will be updated.
    11:50-12:50

  • 13:50-14:30

    Keynote Lecture 5

    Organizer: Hyung Jin Choi (Seoul National University, Republic of Korea)

    • Professor Zachary Knight is a pioneer in the field of elucidating the neural mechanisms of appetite, homeostasis, and obesity, having published some of the finest research in Nature, Cell, and elsewhere over the past few years. His use of potent neuroscience tools is always accompanied by a profound understanding of concepts related to appetite. In this keynote lecture, he will present his most recent findings regarding the function of neural circuits in the brainstem in regulating eating behavior.
    • • References
      1. Nature. Dopamine subsystems that track internal states. 2022
      2. Cell. Genetic identification of vagal sensory neurons that control feeding. 2019
    13:50-14:20 How Muscle Mass and Metabolism Affects Energy Metabolism and Functional Capacity

    William Evans

    (University of California, Berkeley, USA)
    14:20-14:30 Q&A
  • 14:30-15:10

    Keynote Lecture 6

    Organizer: Soo Lim (Seoul National University, Republic of Korea)

    • Obesity is not only a serious disease in itself, but also a health risk factor that causes various diseases, so governmental plan and policy cooperation are needed. Korean government established and announced the first national obesity management comprehensive plan in 2018 to provide an opportunity to raise public awareness of the importance of obesity prevention and management and to monitor the pregress. In this lecture, I would like to introduce the past, present and future of Korea's national obesity strategy.
    14:30-15:00 Human Adipose Tissue Metabolism: What Happens with Obesity

    Michael D. Jensen

    (Mayo College of Medicine,USA)
    15:00-15:10 Q&A
  • 15:10-15:20

    Break

  • 15:20-16:50

    Symposium 17 : Incretin Therapy from MARS, Bariatric Surgery from VENUS

    will be updated.
    15:20-15:45 Incretin-Based Therapy Before Bariatric Surgery: Will It Be Helpful?

    Mi-Kyung Kim

    (Keimyung University, Korea)
    15:45-16:10

    Po-Chih Chang

    (National Sun Yat-Sen University, Kaohsiung, Taiwan)
    16:10-16:35

    McGowan Barbara

    (Guy's and St Thomas' NHS Foundation Trust, UK)
    16:35-16:50 Panel Discussion

    Chang Hee Jung

    (University of Ulsan, Korea),

    Jun Sung Moon

    (Yeungnam University, Korea)
  • 16:50-17:00

    Break

  • 17:00-17:40

    Keynote Lecture 7

    will be updated.
    17:00-17:30 Semaglutide, a Second-Generation Obesity Medication for the Treatment and Prevention of Cardiometabolic Disease

    W. Timothy Garvey

    (University of Alabama at Birmingham, USA)
    17:30-17:40 Q&A
  • 17:40-18:00

    Closing & Award Ceremony

  • 07:30-08:20

    Breakfast Symposium 5

    will be updated.
    07:30-08:20

  • 08:20-08:30

    Break

  • 08:30-09:10

    Keynote Lecture 4

    Organizer: Soo Lim (Seoul National University, Republic of Korea)

    • Obesity is not only a serious disease in itself, but also a health risk factor that causes various diseases, so governmental plan and policy cooperation are needed. Korean government established and announced the first national obesity management comprehensive plan in 2018 to provide an opportunity to raise public awareness of the importance of obesity prevention and management and to monitor the pregress. In this lecture, I would like to introduce the past, present and future of Korea's national obesity strategy.
    08:30-09:00 Cardiometabolic Health: Importance of Lifestyle Vital Signs

    Jean-Pierre Després

    (VITAM - Research Centre on Sustainable Health, Canada)
    09:00-09:10 Q&A
  • 09:10-09:20

    Break

  • 09:20-10:50

    Symposium 14 : Understanding Aging Skeletal Muscle and Dynamics

    Organizer: Il-Young Kim (Gachon University, Republic of Korea), Seung-Hwan Lee (The Catholic University of Korea, Republic of Korea)

    • In this session, latest research on the important role of optimal provision of nutrition (e.g., essential amino acids and proteins) and/or exercise for one’s overall metabolic health with the focus on skeletal muscle and the liver will be discussed. The two most important metabolic organs in the body will be discussed by world-renowned metabolic researchers who have extensive experience in the use of stable isotope tracer methodology and/or traditional biological tools in dissecting in vivo human metabolism in relation to various aspects of human (animal) pathophysiology, such as obesity, insulin resistance, type 2 diabetes, NAFLD, and sarcopenia.
    • • References
      1. Weijs PJ, Wolfe RR. Exploration of the protein requirement during weight loss in obese adults. Clin Nutr 35(2):394-8, Apr 2016. PMID:25788405.
      2. Fordham TM et al., Metabolic effects of an essential amino acid supplement in adolescents with PCOS and obesity, Obesity, 2023 (in revision).
      3. Jang et al., Balanced Free Essential Amino Acids and Resistance Exercise Training Synergistically Improve Dexamethasone-Induced Impairments in Muscle Strength, Endurance, and Insulin Sensitivity in Mice, Int J Mol Sci 202. PMID: 36077132
    09:20-09:45 Sarcopenia: New Insights for a Unified Definition

    William Evans

    (University of California, Berkeley, USA)
    09:45-10:10 Understanding Skeletal Muscle Mass, Protein Dynamics, Regulation and Function Using New Tracer Techniques

    Marc Hellerstein

    (University of California, Berkeley, USA)
    10:10-10:35 Overcoming Anabolic Resistance to Exercise in Sarcopenia: Role of Free Essential Amino Acids

    Il-Young Kim

    (Gachon University, Korea)
    10:35-10:50 Panel Discussion
  • 10:50-11:00

    Break

  • 11:00-11:40

    Presidential Lecture

    Organizer: Soo Lim (Seoul National University, Republic of Korea), Jun Hwa Hong (Eulji University, Republic of Korea)

    • The interplay between adipose tissue's function as an energy reservoir and an endocrine organ is crucial for maintaining metabolic health. A key player in this dynamic balance is leptin, a hormone whose regulation is tightly linked to fat mass. Here we will discuss the multifaceted role of LATS1/2-YAP/TAZ signaling in regulating adipocyte plasticity and leptin production to maintain metabolic homeostasis.
    • • References
      1. Sethi, J.K. and A.J. Vidal-Puig, Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res, 2007. 48(6): p. 1253-62.
      2. Halder, G. and R.L. Johnson, Hippo signaling: growth control and beyond. Development, 2011. 138(1): p. 9-22.
    11:00-11:30

    Cheol-Young Park

    (Sungkyunkwan University, Korea)
    11:30-11:40 Q&A

  • 11:40-11:50

    Break

  • 11:50-12:50

    Luncheon Symposium 6

    will be updated.
    11:50-12:50

  • 13:50-14:30

    Keynote Lecture 5

    Organizer: Hyung Jin Choi (Seoul National University, Republic of Korea)

    • Professor Zachary Knight is a pioneer in the field of elucidating the neural mechanisms of appetite, homeostasis, and obesity, having published some of the finest research in Nature, Cell, and elsewhere over the past few years. His use of potent neuroscience tools is always accompanied by a profound understanding of concepts related to appetite. In this keynote lecture, he will present his most recent findings regarding the function of neural circuits in the brainstem in regulating eating behavior.
    • • References
      1. Nature. Dopamine subsystems that track internal states. 2022
      2. Cell. Genetic identification of vagal sensory neurons that control feeding. 2019
    13:50-14:20 How Muscle Mass and Metabolism Affects Energy Metabolism and Functional Capacity

    William Evans

    (University of California, Berkeley, USA)
    14:20-14:30 Q&A
  • 14:30-15:10

    Keynote Lecture 6

    Organizer: Soo Lim (Seoul National University, Republic of Korea)

    • Obesity is not only a serious disease in itself, but also a health risk factor that causes various diseases, so governmental plan and policy cooperation are needed. Korean government established and announced the first national obesity management comprehensive plan in 2018 to provide an opportunity to raise public awareness of the importance of obesity prevention and management and to monitor the pregress. In this lecture, I would like to introduce the past, present and future of Korea's national obesity strategy.
    14:30-15:00 Human Adipose Tissue Metabolism: What Happens with Obesity

    Michael D. Jensen

    (Mayo College of Medicine,USAa)
    15:00-15:10 Q&A
  • 15:10-15:20

    Break

  • 15:20-16:50

    Symposium 18 : Cracking the Neural Code: Understanding Obesity through the Hypothalamus, Brain Stem, and Vagus Pathways

    Organizer : Hyung Jin Choi (Seoul National University, Korea)

    • The brainstem and hypothalamus intricately orchestrate physiological processes, including appetite regulation and body weight maintenance, by modulating the hunger and satiety. Prof. Jo-Eun Son will elucidate the hypothalamus's mechanism in the genetic determinants of human obesity, Prof. Chen Ran will reveal on the neural encoding of internal senses within the brainstem, and Prof. Zhan Cheng will discuss the function of brainstem catecholaminergic neurons in the regulation of energy homeostasis.
    • • References
      1. 2021 Nature Metabolism. Irx3 and Irx5 in Ins2-Cre+ cells regulate hypothalamic postnatal neurogenesis and leptin response
      2021 Science Advances. Ectopic expression of Irx3 and Irx5 in the paraventricular nucleus of the hypothalamus contributes to defects in Sim1 haploinsufficiency
      2. 2022 Nature. A brainstem map for visceral sensations
      3. 2024 Nature Neuroscience. Fasting-activated ventrolateral medulla neurons regulate T cell homing and suppress autoimmune disease in mice
      2023 Cell Reports. AgRP neurons are not indispensable for body weight maintenance in adult mice
    15:20-15:45 Hypothalamic Function of IRX3 and IRX5: Genetic Determinants of Human Obesity

    Joe Eun Son

    (Kyungpook National University, Korea)
    15:45-16:10 The Coding of Internal Senses in the Brainstem

    Chen Ran

    (The Scripps Research Institute, USA)
    16:10-16:35 Roles of Brainstem Catecholaminergic Neurons in Control of Energy Homeostasis

    Zhan Cheng

    (University of Science and Technology of China, China)
    16:35-16:50 Panel Discussion

    Yong Taek Jeong

    (Korea University, Korea),

    Chan Hee Lee

    (Hallym University, Korea)
  • 16:50-17:00

    Break

  • 17:00-17:40

    Keynote Lecture 7

    will be updated.
    17:00-17:30 Semaglutide, a Second-Generation Obesity Medication for the Treatment and Prevention of Cardiometabolic Disease

    W. Timothy Garvey

    (University of Alabama at Birmingham, USA)
    17:30-17:40 Q&A
  • 17:40-18:00

    Closing & Award Ceremony

  • 07:30-08:20

    Breakfast Symposium 6

    will be updated.
    07:30-08:20

  • 08:20-08:30

    Break

  • 08:30-09:10

    Keynote Lecture 4

    Organizer: Jae Geun Kim (Incheon National University, Republic of Korea)

    • Professor Tamas Horvath is Chair of the Department of Comparative Medicine at Yale University School of Medicine in the United States and one of the leading researchers in the field of study on the hypothalamic control of energy homeostasis. In particular, his research on the regulation of synaptic plasticity by AgRP neurons in hypothalamic neuronal circuitries is one of his most noteworthy accomplishments. In this session, Professor Horvath will introduce the role of hypothalamic AgRP neurons that can be applied to obesity treatment.
    • • References
      1. Hunger-promoting AgRP neurons trigger an astrocyte-mediated feed-forward autoactivation loop in mice. J Clin Invest. 2021
      2. AgRP neurons control compulsive exercise and survival in an activity-based anorexia model. Nature Metabolism. 2020.
    08:30-09:00 Cardiometabolic Health: Importance of Lifestyle Vital Signs

    Jean-Pierre Després

    (VITAM - Research Centre on Sustainable Health, Canada)
    09:00-09:10 Q&A
  • 09:10-09:20

    Break

  • 09:20-10:50

    Symposium 15 : Diet Quality and Weight Regulation

    Organizer: Hyunjung Lim (Kyung Hee University), Sujin Song (Hannam University), Oh Yoen Kim (Dong-A University)

    • Obesity is no longer an individual or family problem but is recognized as a disease that society must solve together. It is also pointed out as a cause of socially enormous economic loss and class polarization. This session introduces community-based nutrition interventions and approaches for obesity management in vulnerable groups. The first speaker Dr. Shirley Y. Chao from the Massachusetts Executive Office of Elder Affairs in the USA will lecture on ‘Integrating Frailty and Malnutrition Screening into Community Care for Older Adults and Their Caregivers.' The second speaker Professor Seung Eun Jung from the University of Alabama in the USA will introduce 'Community-based Strategies to Decrease Health Disparities and Improve Nutritional Status for US Low-income Population.' Lastly, Professor Minsun Jeon of Chungnam National University in the Republic of Korea lectures on 'Nutrition Management Strategies for the Elderly and the Disabled in Social Welfare Facilities' and discusses obesity management in vulnerable groups in this session.
    • • References
      1. Chao S, Corish CA, Keller H, Rasmussen H, Arensberg MB, Dwyer JT.
      Are you prepared for the decade of healthy aging 2020-2030? A panel summary from the academy of nutrition and dietetics 2020 food & nutrition conference & expo virtual event, Nutrition Today 56(4):183-192, 2021.
      2. Jung SE, Shin YH, Kim H, Hermann J, Bice C. Identifying Underlying Beliefs About Fruit and Vegetable Consumption Among Low-Income Older Adults: An Elicitation Study Based on the Theory of Planned Behavior, J Nutr Educ Behav. 49(9):717-723, 2017
      3. Han S, Jeon M Development and Application of Nutrition Education Program for the Elderly in Low Income Korean Journal of Human Ecology. 28(2):171-183, 2019.
    09:20-09:45

    Yuri Kim

    (Ewha Womans University, Korea)
    09:45-10:10 Optimal Diets for Body Weight Management

    Yang Hu

    (Harvard University, USA)
    10:10-10:35 Trends in Diet Quality and Cardiometabolic Risk Factors Among Korean Adults

    Hannah Oh

    (Korea University, Korea)
    10:35-10:50 Panel Discussion
  • 10:50-11:00

    Break

  • 11:00-11:40

    Presidential Lecture

    Organizer: Soo Lim (Seoul National University, Republic of Korea), Jun Hwa Hong (Eulji University, Republic of Korea)

    • The interplay between adipose tissue's function as an energy reservoir and an endocrine organ is crucial for maintaining metabolic health. A key player in this dynamic balance is leptin, a hormone whose regulation is tightly linked to fat mass. Here we will discuss the multifaceted role of LATS1/2-YAP/TAZ signaling in regulating adipocyte plasticity and leptin production to maintain metabolic homeostasis.
    • • References
      1. Sethi, J.K. and A.J. Vidal-Puig, Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res, 2007. 48(6): p. 1253-62.
      2. Halder, G. and R.L. Johnson, Hippo signaling: growth control and beyond. Development, 2011. 138(1): p. 9-22.
    11:00-11:30

    Cheol-Young Park

    (Sungkyunkwan University, Korea)
    11:30-11:40 Q&A

  • 11:40-11:50

    Break

  • 11:50-12:50

    Luncheon Symposium 7

    will be updated.
    11:50-12:50

  • 13:50-14:30

    Keynote Lecture 5

    Organizer: Hyung Jin Choi (Seoul National University, Republic of Korea)

    • Professor Zachary Knight is a pioneer in the field of elucidating the neural mechanisms of appetite, homeostasis, and obesity, having published some of the finest research in Nature, Cell, and elsewhere over the past few years. His use of potent neuroscience tools is always accompanied by a profound understanding of concepts related to appetite. In this keynote lecture, he will present his most recent findings regarding the function of neural circuits in the brainstem in regulating eating behavior.
    • • References
      1. Nature. Dopamine subsystems that track internal states. 2022
      2. Cell. Genetic identification of vagal sensory neurons that control feeding. 2019
    13:50-14:20 How Muscle Mass and Metabolism Affects Energy Metabolism and Functional Capacity

    William Evans

    (University of California, Berkeley, USA)
    14:20-14:30 Q&A
  • 14:30-15:10

    Keynote Lecture 6

    Organizer: Soo Lim (Seoul National University, Republic of Korea)

    • Obesity is not only a serious disease in itself, but also a health risk factor that causes various diseases, so governmental plan and policy cooperation are needed. Korean government established and announced the first national obesity management comprehensive plan in 2018 to provide an opportunity to raise public awareness of the importance of obesity prevention and management and to monitor the pregress. In this lecture, I would like to introduce the past, present and future of Korea's national obesity strategy.
    14:30-15:00 Human Adipose Tissue Metabolism: What Happens with Obesity

    Michael D. Jensen

    (Mayo College of Medicine,USA)
    15:00-15:10 Q&A
  • 15:10-15:20

    Break

  • 15:20-16:50

    Symposium 19 : Expanding Horizons in Pediatric Obesity

    will be updated.
    15:20-15:45 The Effects of Physical Activity on Obesity and Health in Adolescents

    Jihyun Ahn

    (Kyeongin High School, Korea)
    15:45-16:10 Understanding Pediatric Obesity from a Social Work Perspective

    Eunji Nam

    (Incheon National University, Korea)
    16:10-16:35 The Effectiveness of Social Media Nutrition Education for Promoting Locally Grown Fruit and Vegetable Consumption Among College Students

    Seung Eun Jung

    (The University of Alabama, USA)
    16:35-16:50 Panel Discussion
  • 16:50-17:00

    Break

  • 17:00-17:40

    Keynote Lecture 7

    will be updated.
    17:00-17:30 Semaglutide, a Second-Generation Obesity Medication for the Treatment and Prevention of Cardiometabolic Disease

    W. Timothy Garvey

    (University of Alabama at Birmingham, USA)
    17:30-17:40 Q&A
  • 17:40-18:00

    Closing & Award Ceremony

  • 09:20-10:50

    Symposium 16

    will be updated.
    09:20-09:45

    09:45-10:10

    10:10-10:35

    10:35-10:50 Panel Discussion
  • 12:50-13:50

    Oral Presentation 3

    will be updated.
    12:50-13:00

    13:00-13:10

    13:10-13:20

    13:20-13:30

    13:30-13:40

  • 15:20-16:50

    Symposium 20 : Exercise and Cardiometabolic Dysfunction

    will be updated.
    15:20-15:45 Impact of Progressive Dynamic Resistance Training on Skeletal Muscle and Vascular Function in Older Adults

    Oh Sung Kwon

    (University of Connecticut, USA)
    15:45-16:10 Sleep, Metabolic Diseases, and the Role of Physical Activity in Middle and Older Individuals

    Jaehoon Seol

    (University of Tsukuba, Japan)
    16:10-16:35

    Min-Hwa Suk

    (Seoul National University of Education, Korea)
    16:35-16:50 Panel Discussion
  • 09:20-10:50

    Sponsored Session 3

    will be updated.
    09:20-09:50

    09:50-10:20

    10:20-10:50

  • 12:50-13:50

    Oral Presentation 4

    will be updated.
    12:50-13:00

    13:00-13:10

    13:10-13:20

    13:20-13:30

    13:30-13:40

  • 15:20-16:30

    Joint Symposium KSSO-TOS

    will be updated.
    15:20-15:45

    15:45-16:10

    16:10-16:35

    16:35-16:50 Panel Discussion

  • 12:50-13:50

    Guided Poster Presentation 2

    will be updated.
    12:50-13:00

    13:00-13:10

    13:10-13:20

    13:20-13:30

    13:30-13:40